By drug class, the global anxiety disorders and depression treatment market is segmented into selective serotonin reuptake inhibitors (SSRIs), anticonvulsants, serotonin-norepinephrine reuptake inhibitors (SNRIs), beta-blockers, atypical antipsychotics, benzodiazepines, monoamine oxidase
inhibitors (MAOIs), tricyclic antidepressants (TCAs), and tetracyclic antidepressants (TeCAs).
Aim of this study was to test the monoamine oxidase
(MAO) inhibition activity of the same AFA extract and of its constituents phycocyanin (AFA-PC) and mycosporine-like aminoacids (AFA-MAAs).
Rasagiline is a monoamine oxidase
B (MAO-B) inhibitor which is presumed to act by increasing available synaptic dopamine in the brain which may improve the motor symptoms characteristic of Parkinson s disease.
A (MAO-A) is an enzyme that breaks down serotonin, norephinephrine and dopamine, neurotransmitters well-known for their influence on emotion and mood.
Brain neurotransmitters play a key role in female sexual dysfunction, notably the compound monoamine oxidase
Both agents are known reversible monoamine oxidase
inhibitors and when either is administered along with a serotonergic medication, high levels of serotonin can build up in the brain resulting in serotonin syndrome, which is characterized by symptoms that include mental changes.
Thus, the objective of this article is to provide the reader with a brief overview of monoamine oxidase
A (MAOA) genotyping and what might be some questions and implications to consider from a Canadian perspective.
Boosting them before giving birth could provide just enough cushion to counteract the effects of increased monoamine oxidase
Greater levels of a brain protein called monoamine oxidase
A (MAO-A) may explain why postpartum blues and clinical depression are so common after childbirth, according to study published recently in the Archives of General Psychiatry.
Recently researchers in Geneva set out to determine whether extracts of Rhodiola radix had any effect on the monoaminergic system, specifically on the monoamine oxidase
enzyme systems (MAO A and MAO B).
The gene, a variation of the Monoamine oxidase
MAOA), affects levels of brain chemicals dopamine and serotonin which affect behaviour and mood.
One sampling of specific topics turns up metabolic syndrome in drug abuse, brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity, nanodevices for neuro-modulation, and the effect of methylene blue and related redox dyes on monoamine oxidase
activity as revealed by rats and frogs.